Atsuko Hosokawa

625 citations
9 papers · 530 indexed · h-index 6
Topics
Pharmacological Effects and Toxicity Studies (2 papers)Parathyroid Disorders and Treatments (2 papers)Cancer Treatment and Pharmacology (2 papers)

In The Last Decade

Atsuko Hosokawa

9 papers receiving 519 citations

Peers

Atsuko Hosokawa
Comparison fields: 5 of 81
  • Nephrology 272
  • Molecular Biology 142
  • Physiology 69
  • Oncology 64
  • Pediatrics, Perinatology and Child Health 53
Replace Cristina Vázquez‐Carballo with:
Cristina Vázquez‐Carballo Spain
S. Rovidati Italy
Toshihiro Asai Japan
Toshimitsu Niwa Japan
Yin Li China
Rafael Rodríguez‐Muñoz Mexico
Bingbing Zhu China
Akihiko Matsuda Japan
Yuebo Huang China
Atsuko Hosokawa relative to Cristina Vázquez‐Carballo Spain Cristina Vázquez‐Carballo's profile →
Citations per field
00.5×
Cristina Vázquez‐Carballo · 1×
Citations per year

Countries citing papers authored by Atsuko Hosokawa

Since Specialization
Citations

This map shows the geographic impact of Atsuko Hosokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Hosokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Hosokawa more than expected).

Fields of papers citing papers by Atsuko Hosokawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Hosokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Hosokawa. The network helps show where Atsuko Hosokawa may publish in the future.

Co-authorship network of co-authors of Atsuko Hosokawa

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuko Hosokawa. A scholar is included among the top collaborators of Atsuko Hosokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuko Hosokawa. Atsuko Hosokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1
[Prospective study of biotin treatment in patients with erythema due to gefitinib or erlotinib].
2
2
[A case of paclitaxel-induced peripheral neuropathy successfully treated with pregabalin].
5
3
[A case of neurotoxicity reduced with pregabalin in R-CHOP chemotherapy for diffuse large B-cell lymphoma].
1
4 63
5 19
6 58
7 242
8 97
9 43

About Atsuko Hosokawa

Atsuko Hosokawa is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Orthopedics and Sports Medicine, having authored 9 papers that have together received 530 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (2 papers), Parathyroid Disorders and Treatments (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Nephrology (272 citations), Clinical Biochemistry (39 citations) and Biological Psychiatry (9 citations). Atsuko Hosokawa has collaborated with scholars based in Japan, Thailand and United States. Frequent co-authors include Hideyuki Yamato, Masaru Motojima, Toshimasa Yoshioka, Takamura Muraki, Yoshiko Iwasaki, Ayako Fujieda, Motoyuki Uchida, Tomoko Nii‐Kono, Masafumi Fukagawa and Mamoru Harada. Their work appears in journals such as Kidney International, British Journal of Pharmacology and Phytochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026